CL2012003253A1 - Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico. - Google Patents

Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico.

Info

Publication number
CL2012003253A1
CL2012003253A1 CL2012003253A CL2012003253A CL2012003253A1 CL 2012003253 A1 CL2012003253 A1 CL 2012003253A1 CL 2012003253 A CL2012003253 A CL 2012003253A CL 2012003253 A CL2012003253 A CL 2012003253A CL 2012003253 A1 CL2012003253 A1 CL 2012003253A1
Authority
CL
Chile
Prior art keywords
compounds
chalconas
trpv
alkylamides
thiadiazole
Prior art date
Application number
CL2012003253A
Other languages
English (en)
Inventor
Olavarria Miguel De La Cruz Zarraga
Ulloa Sebastian Esteban Brauchi
Rebolledo Carolyne Andrea Lespey
Original Assignee
Univ Concepcion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Concepcion filed Critical Univ Concepcion
Priority to CL2012003253A priority Critical patent/CL2012003253A1/es
Publication of CL2012003253A1 publication Critical patent/CL2012003253A1/es
Priority to PCT/CL2013/000085 priority patent/WO2014078971A1/es
Priority to US14/646,655 priority patent/US20160039778A1/en
Priority to EP13857010.6A priority patent/EP2924028A4/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/121,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles
    • C07D285/1251,3,4-Thiadiazoles; Hydrogenated 1,3,4-thiadiazoles with oxygen, sulfur or nitrogen atoms, directly attached to ring carbon atoms, the nitrogen atoms not forming part of a nitro radical
    • C07D285/135Nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • A61K31/122Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433Thidiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/80Ketones containing a keto group bound to a six-membered aromatic ring containing halogen
    • C07C49/807Ketones containing a keto group bound to a six-membered aromatic ring containing halogen all halogen atoms bound to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/82Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups
    • C07C49/825Ketones containing a keto group bound to a six-membered aromatic ring containing hydroxy groups all hydroxy groups bound to the ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/76Ketones containing a keto group bound to a six-membered aromatic ring
    • C07C49/84Ketones containing a keto group bound to a six-membered aromatic ring containing ether groups, groups, groups, or groups

Abstract

Compuestos derivados de 1,3,4-Tiadiazol Alquilamidas y de chalconas, antagonistas del receptor TRPV-1; uso de los compuestos para tratar el dolor crónico.
CL2012003253A 2012-11-22 2012-11-22 Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico. CL2012003253A1 (es)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CL2012003253A CL2012003253A1 (es) 2012-11-22 2012-11-22 Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico.
PCT/CL2013/000085 WO2014078971A1 (es) 2012-11-22 2013-11-21 Compuesto antagonista del receptor trpv-1, derivados de 1,3,4-tiadiazol alquilamidas y de chalconas
US14/646,655 US20160039778A1 (en) 2012-11-22 2013-11-21 Trpv-1 receptor antagonist compound derived from 1,3,4-thiadiazole alkylamides and chalcones
EP13857010.6A EP2924028A4 (en) 2012-11-22 2013-11-21 TRPV-1 RECEPTOR ANTAGONIST COMPOUND, 1,3,4-TIADIAZOLE ALKYLAMIDE AND CHALCONES DERIVATIVES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2012003253A CL2012003253A1 (es) 2012-11-22 2012-11-22 Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico.

Publications (1)

Publication Number Publication Date
CL2012003253A1 true CL2012003253A1 (es) 2013-01-11

Family

ID=50775362

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012003253A CL2012003253A1 (es) 2012-11-22 2012-11-22 Compuestos derivados de 1,3,4-tiadiazol alquilamidas y de chalconas, antagonistas del receptor trpv-1; uso de los compuestos para tratar el dolor cronico.

Country Status (4)

Country Link
US (1) US20160039778A1 (es)
EP (1) EP2924028A4 (es)
CL (1) CL2012003253A1 (es)
WO (1) WO2014078971A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112694392B (zh) * 2020-12-21 2022-11-22 青岛大学 一种trpv3抑制剂及其制备方法
CN115105503B (zh) * 2022-07-20 2023-05-23 河南大学 一种trpv1拮抗/cox抑制双靶点药物或其药学上可接受的盐、药物制剂和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ231534A (en) * 1988-11-29 1992-02-25 Warner Lambert Co 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions
CN1665808A (zh) * 2002-05-06 2005-09-07 沃泰克斯药物股份有限公司 噻二唑或噁二唑及其作为jak蛋白激酶抑制剂的用途
EP2050734A1 (en) * 2006-07-13 2009-04-22 Kyowa Hakko Kirin Co., Ltd. Pentadienamide derivative
WO2009090548A2 (en) * 2008-01-17 2009-07-23 Glenmark Pharmaceuticals, S.A. 3-azabicyclo [3.1.0] hexane derivatives as vanilloid receptor ligands
EP2590957B1 (en) * 2010-07-09 2014-11-12 Pfizer Limited N-sulfonylbenzamides as inhibitors of voltage-gated sodium channels

Also Published As

Publication number Publication date
EP2924028A4 (en) 2016-09-07
WO2014078971A1 (es) 2014-05-30
EP2924028A1 (en) 2015-09-30
US20160039778A1 (en) 2016-02-11

Similar Documents

Publication Publication Date Title
CL2017001987A1 (es) Derivados de 1-(het)arilsulfonil-(pirrolidin o piperidin)-2-carboxamida y su uso como antagonistas de trpa1
DOP2015000270A (es) Potenciador de inhibidores del homólogo de zeste
CL2016000153A1 (es) Derivados de pirrolamida sustituidos con glioxamida y su uso como medicamentos para el tratamiento de la hepatitis b
CR20150472A (es) USO DE DERIVADOS DE PIRAZOLOPIRIMIDINA PARA EL TRATAMIENTO DE TRANSTORNOS RELACIONADOS CON LA PI3Kd
CL2015000942A1 (es) Compuestos de benceno sustituido.
CL2016000922A1 (es) Derivados de anillo bicíclico fusionado piridilo como inhibidores fgfr4
CL2015002767A1 (es) Compuestos terapéuticos y composiciones
CL2016000106A1 (es) Sulfonamidas como moduladores de canales de sodio.
EA201691259A1 (ru) РЕГУЛЯТОРЫ Nrf2
UA113440C2 (xx) Сполуки тетрагідропіразолопіримідину
CR20150524A (es) Compuestos de heteroarilo y sus usos
EA201591728A1 (ru) Гетероциклические соединения и способы их применения
TR201902516T4 (tr) Glukagon-glp-1-gıp üçlü agonist bileşikleri.
CL2015003314A1 (es) Inhibidores de acc y usos de los mismos
UY35590A (es) Nuevos compuestos para el tratamiento del cáncer
CL2015001377A1 (es) Inhbibidores de bmi-1 primidinas sustituidas inversas
EA201691070A1 (ru) Новые трициклические соединения в качестве противораковых средств
PE20151436A1 (es) Moduladores de receptores nmda de espiro-lactama y sus usos
ECSP16012582A (es) Compuestos heterocíclicos y métodos de uso
GT201700023A (es) Derivados de heterociclico opcionalmente condensados de piridimina útiles para el tratamiento de enfermedades inflamatorias, metabolicas, oncológicas y autoinmunitarias
ECSP13012573A (es) 6-amino-nicotinamidas sustituidas como moduladores de KCNQ2/3
CL2015002202A1 (es) Benzamidas sustituidas con actividad hacia receptores ep4.
ECSP17074645A (es) Azabenzimidazoles y su uso como moduladores del receptor ampa
NI201500050A (es) Benzamidas
EA201490037A1 (ru) Антагонисты trpv4